The National Dairy Development Board (NDDB) set up Indian Immunologicals Ltd. (IIL) in 1982 with the objective of making Foot and Mouth Disease (FMD) vaccine available to farmers at an affordable price. The technology for FMD vaccine manufacture was obtained from M/s. Wellcome Foundation Limited, United Kingdom. The plant in Hyderabad today has a capacity to make 80 million trivalent doses of FMD vaccine. Following the successful introduction of Foot &Mouth Disease Vaccine-Raksha, IIL launched the tissue culture vaccine Raksharab"_ in 1989. This was the first Indian tissue culture vaccine in the market. Subsequently IIL has developed many biologicals through its own R&D efforts and launched several vaccines in the Indian market at affordable prices. IIL is today the fifth largest animal health player in the Indian market and the market leader in veterinary biologicals in India. It operates one of the largest plants in the world for veterinary vaccines and is WHO-GMP and ISO-9001 certified. IIL exports its products to several countries and exports contributed substantially to the company's turnover.